Evidence map›Paper›PMID 41675961›Full record

ArticleQuantitative biology (Beijing, China)2025

Complex non-Markovian dynamics and the dual role of astrocytes in Alzheimer's disease development and propagation.

Swadesh Pal, Roderick Melnik

Abstract read
In one paragraph

Article in Quantitative biology (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Swadesh PalMS2 Discovery Interdisciplinary Research Institute Wilfrid Laurier University Waterloo ON Canada.ORCID https://orcid.org/0000-0002-6873-7338
Roderick MelnikMS2 Discovery Interdisciplinary Research Institute Wilfrid Laurier University Waterloo ON Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disorder nowadays. Amyloid-beta (Aβ) and tau proteins are among the main contributors to the AD progression. In AD, Aβ proteins clump together to form plaques and disrupt cell functions. On the other hand, the abnormal chemical change in the brain helps to build sticky tau tangles that block the neuron's transport system. Astrocytes generally maintain a healthy balance in the brain by clearing the Aβ plaques (toxic Aβ). However, overactivated astrocytes release chemokines and cytokines in the presence of Aβ and react to pro-inflammatory cytokines, further increasing the production of Aβ. In this study, we construct a mathematical model that can capture astrocytes' dual behavior. Furthermore, we reveal that the disease progression depends on the current time instance and the disease's earlier status, called the "memory effect," making non-Markovian processes an appropriate approach. We consider a fractional order network mathematical model to capture the influence of such memory effects on AD progression. We have integrated brain connectome data into the model and studied the memory effect, the dual role of astrocytes, and the brain's neuronal damage. Based on the pathology, primary, secondary, and mixed tauopathies parameters are considered in the model. Due to the mixed tauopathy, different brain nodes or regions in the brain connectome accumulate different toxic concentrations of Aβ and tau proteins. Finally, we explain how the memory effect can slow down the propagation of such toxic proteins in the brain, decreasing the rate of neuronal damage.

Indexed as

Alzheimer’s disease and neurodegenerationastrocytesbrain connectomeCaputo fractional derivativesdata‐driven modelingnetwork modelsnon‐Markovian processes

Identifiers

PMID41675961
PMCPMC12806121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.